Association of Intravenous Immunoglobulin Therapy With Healthcare Utilization in Immunodeficient Adults With Chronic Rhinosinusitis

Documenti analoghi

• Regulatory T and B cells in transient hypogammaglobulinemia of infancy
  di: Ayça Emsen, et al.
  Pubblicazione: (2022-04-01)
• Fresh-frozen plasma as a low-cost replacement of intravenous immunoglobulin for the treatment of symptomatic hypogammaglobulinemia
  di: Pankaj Kumar, et al.
  Pubblicazione: (2023-01-01)
• Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored
  di: Qinggang Zhang, et al.
  Pubblicazione: (2024-03-01)
• Prophylactic immunoglobulin therapy for pediatric congenital myotonic dystrophy
  di: Yoji Uejima, et al.
  Pubblicazione: (2024-04-01)
• Longitudinal changes of serum immunoglobulins under ocrelizumab: factors associated with hypogammaglobulinemia and infection risk in a real-world multiple sclerosis cohort
  di: Amelie Bohn, et al.
  Pubblicazione: (2026-06-01)